Log In
Print this Print this

WTCc (ABX196)

  Manage Alerts
Collapse Summary General Information
Company Abivax S.A.S.
DescriptionAdjuvant to boost NKT and B cell response based on proprietary technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPhase I
Standard IndicationAdjuvant
Indication DetailsAdjuvant for vaccines
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today